Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 20101 - 20125 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cupric oxide	Approved	PABPC3	5042	downregulated	cupric oxide results in decreased expression of PABPC3 mRNA	13q12.13	A21783
Cupric oxide	Approved	PAIP2	51247	upregulated	cupric oxide results in increased expression of PAIP2 mRNA	5q31.2	A21783
Cupric oxide	Approved	PALD1	27143	downregulated	cupric oxide results in decreased expression of PALD1 mRNA	10q22.1	A21783
Cupric oxide	Approved	PAPOLA	10914	upregulated	cupric oxide results in increased expression of PAPOLA mRNA	14q32.2	A21783
Cupric oxide	Approved	PARP4	143	downregulated	cupric oxide results in decreased expression of PARP4 mRNA	13q12.12	A21783
Cupric oxide	Approved	PCDH9	5101	downregulated	cupric oxide results in decreased expression of PCDH9 mRNA	13q21.32	A21783
Cupric oxide	Approved	PCF11	51585	upregulated	cupric oxide results in increased expression of PCF11 mRNA	11q14.1	A21783
Cupric oxide	Approved	PCNA	5111	downregulated	cupric oxide results in decreased expression of PCNA mRNA	20p12.3	A21783
Cupric oxide	Approved	PDGFA	5154	downregulated	cupric oxide results in decreased expression of PDGFA mRNA	7p22.3	A21783
Cupric oxide	Approved	PHC3	80012	upregulated	cupric oxide results in increased expression of PHC3 mRNA	3q26.2	A21783
Cupric oxide	Approved	PHF1	5252	upregulated	cupric oxide results in increased expression of PHF1 mRNA	6p21.32	A21783
Cupric oxide	Approved	PHTF1	10745	upregulated	cupric oxide results in increased expression of PHTF1 mRNA	1p13.2	A21783
Cupric oxide	Approved	PIF1	80119	downregulated	cupric oxide results in decreased expression of PIF1 mRNA	15q22.31	A21783
Cupric oxide	Approved	PLAGL1	5325	downregulated	cupric oxide results in decreased expression of PLAGL1 mRNA	6q24.2	A21783
Cupric oxide	Approved	PLK2	10769	downregulated	cupric oxide results in decreased expression of PLK2 mRNA	5q11.2	A21783
Cupric oxide	Approved	PLRG1	5356	upregulated	cupric oxide results in increased expression of PLRG1 mRNA	4q31.3	A21783
Cupric oxide	Approved	PMS1	5378	downregulated	cupric oxide results in decreased expression of PMS1 mRNA	2q32.2	A21783
Cupric oxide	Approved	PMS2P2	5380	upregulated	cupric oxide results in increased expression of PMS2P2 mRNA	7q11.23	A21783
Cupric oxide	Approved	PNPLA8	50640	upregulated	cupric oxide results in increased expression of PNPLA8 mRNA	7q31.1	A21783
Cupric oxide	Approved	PODXL	5420	downregulated	cupric oxide results in decreased expression of PODXL mRNA	7q32.3	A21783
Cupric oxide	Approved	POLI	11201	downregulated	cupric oxide results in decreased expression of POLI mRNA	18q21.2	A21783
Cupric oxide	Approved	PPP1R3B	79660	upregulated	cupric oxide results in increased expression of PPP1R3B mRNA	8p23.1	A21783
Cupric oxide	Approved	PROP1	5626	upregulated	cupric oxide results in increased expression of PROP1 mRNA	5q35.3	A21783
Cupric oxide	Approved	PRPF18	8559	upregulated	cupric oxide results in increased expression of PRPF18 mRNA	10p13	A21783
Cupric oxide	Approved	PRSS23	11098	downregulated	cupric oxide results in decreased expression of PRSS23 mRNA	11q14.2	A21783

Displaying entries 20101 - 20125 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability